BUENOS AIRES--(BUSINESS WIRE)--GridX, Latin America's largest biotechnology investment fund and company builder, is set to begin its international Roadshow featuring 21 innovative startups across ...

As the world enters an age of biotechnology, there is emerging evidence that China is “distorting” biotechnology markets and is quickly ascending to “dominance” in this field, having made ...

One relatively small biotech company has made a breakthrough that could be used to treat a range of cancer. While it's been a poor performer for the past few years despite promising growth ...

A pioneer in Taiwan’s advanced manufacturing cell technologies, YJ Biotechnology has quickly established itself as one of the country’s leading names in the development of regenerative medicine.

As explained by Mr. Maick Su, CEO of NanoRay Biotech, AMT is a “first-in-human” combination therapy that applies IuDR, an iodinated analog of thymidine that can be used as a component of DNA ...

Passed by the House in September 2024, the Biosecure Act took a particularly hardline stance on Chinese biotech, denying top firms access to U.S. pharma supply chains. The bill forced U.S ...

Mural Oncology is a biotechnology company that focuses on using its protein engineering platform to develop cytokine-based immunotherapies for cancer treatment. The company aims to deliver ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Relay Therapeutics Inc. (NASDAQ:RLAY ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Geron Corp. (NASDAQ:GERN) stands against ...

I often refer to Regeneron as a “Biotech Juggernaut” because it seems like they have similar strengths to the comic book character. The company appears to have unstoppable momentum thanks to a ...

Abu Dhabi’s state-backed health-care investment company M42 has taken a stake in biotech startup Juvenescence, a UK-based firm focused on developing drugs to expand human lifespans. M42 ...

After San Francisco biotech company Third Harmonic Bio slashed its staff by half in February, it’s now taking a more drastic step. The inflammatory disease research company’s directors have ...